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Abstract
Background: Olfaction is a versatile sensory mechanism for detecting thousands of volatile odorants. Although
molecular basis of odorant signaling is relatively well understood considerable gaps remain in the complete
charting of all relevant gene products. To address this challenge, we applied RNAseq to four well-characterized
human olfactory epithelial samples and compared the results to novel and published mouse olfactory epithelium
as well as 16 human control tissues.
Results: We identified 194 non-olfactory receptor (OR) genes that are overexpressed in human olfactory tissues vs.
controls. The highest overexpression is seen for lipocalins and bactericidal/permeability-increasing (BPI)-fold proteins,
which in other species include secreted odorant carriers. Mouse-human discordance in orthologous lipocalin expression
suggests different mammalian evolutionary paths in this family.
Of the overexpressed genes 36 have documented olfactory function while for 158 there is little or no previous such
functional evidence. The latter group includes GPCRs, neuropeptides, solute carriers, transcription factors and
biotransformation enzymes. Many of them may be indirectly implicated in sensory function, and ~70 % are over
expressed also in mouse olfactory epithelium, corroborating their olfactory role.
Nearly 90 % of the intact OR repertoire, and ~60 % of the OR pseudogenes are expressed in the olfactory epithelium,
with the latter showing a 3-fold lower expression. ORs transcription levels show a 1000-fold inter-paralog variation, as
well as significant inter-individual differences. We assembled 160 transcripts representing 100 intact OR genes. These
include 1–4 short 5’ non-coding exons with considerable alternative splicing and long last exons that contain the
coding region and 3’ untranslated region of highly variable length. Notably, we identified 10 ORs with an intact open
reading frame but with seemingly non-functional transcripts, suggesting a yet unreported OR pseudogenization
mechanism. Analysis of the OR upstream regions indicated an enrichment of the homeobox family transcription
factor binding sites and a consensus localization of a specific transcription factor binding site subfamily (Olf/EBF).
Conclusions: We provide an overview of expression levels of ORs and auxiliary genes in human olfactory epithelium.
This forms a transcriptomic view of the entire OR repertoire, and reveals a large number of over-expressed
uncharacterized human non-receptor genes, providing a platform for future discovery.
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Background
Olfaction, the sense of smell, is a versatile and sensitive
mechanism for detecting and discriminating thousands
of volatile odorants. Olfactory recognition is mediated
by a large repertoire of olfactory receptors (ORs), which
activate a G-protein-mediated transduction cascade [1–4].
The ORs are expressed on the ciliated dendrites of olfac-
tory sensory neurons located in the olfactory epithelium.
Each sensory neurons expresses a single allele of a single
OR gene locus, to ensure a distinct pattern of neuronal ac-
tivation for every odorant [1, 2].
Olfactory epithelium, the tissue analyzed here, is het-
erogonous, containing besides the sensory neurons also
epithelial supporting cells and progenitor basal cells, as
well as sub-epithelial Bowman’s glands cells that secrete
the mucus within which olfactory cilia reside, microvillar
cells, and fingerlike microvilli cells [5]. While in mouse
this tissue is readily available, the human counterpart is
harder to obtain, due to difficulties in dissection and in
defining the exact anatomically boundaries [6]. This
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explains the relative lack of transcriptome information
about human olfactory genes. Overcoming these difficul-
ties, we provide here a whole genome expression view of
the human olfactory tissue.
Olfactory transduction can be divided into ligand bind-
ing, signal generation and signal termination. The end re-
sult is triggering of action potentials conducted along the
axon to the olfactory bulb. A large number of proteins take
part in such processes, as well as in the development and
maintenance of the relevant cellular components [7–9].
Such gene products have been termed “auxiliary”, as por-
trayed in a digital compendium, GOSdb database (http://
genome.weizmann.ac.il/GOSdb/, [10]).
Not all olfactory auxiliary genes have been identified,
and most of them have never been studied in humans.
Physiological differences among mammalian species may
be accompanied with differences at the signal transduc-
tion level as well. For example guanylate cyclase 2D
(Gucy2d, GC-D) gene, which is expressed in specific
subset of OSNs and involved in CO2 detection [4, 11],
was shown to be a pseudogene in humans, and signaling
through this system appears to have been lost during
primate evolution [12]. Here, we employ a broad tran-
scriptome analysis to help fill some of these knowledge
gaps, pertaining to olfactory auxiliary genes.
The human genome contains 857 OR genes, of which
391 are intact and 466 are pseudogenes with disrupting
mutations in the open reading frame [13]. The repertoire
of OR coding regions was deciphered mainly by compu-
tational genome data-mining [10, 14–16]. This informa-
tion is reflected in genomic databases of both human
and mouse, where most OR genes are portrayed with a
partial gene structure that depicts only the coding re-
gion. The general reported ORs gene structure shows a
single exon encompassing both a ~960 bp coding region
and a 3’ untranslated region (3’UTR), with additional 5’
UTR short exons separated by long introns [17–20]. In
mouse, cDNA sequencing and RNAseq, including single
cell RNAseq of olfactory sensory neurons, have provided
considerable specific information on OR gene structure
[18, 20–25]. In contrast, information of the human OR
gene structure is available only for a limited number of
genes. Here we considerably expand this information.
The current study describes the transcriptome ana-
lysis of four human olfactory epithelial samples. We
identified a set of 196 olfactory over expressed genes,
composed of genes with known olfactory functions as
well as novel olfactory candidates. This provides clues
to a large number of uncharted genes which might have
a role in the olfactory epithelium, including chemosen-
sory function.
For OR genes we observed large variation in the expres-
sion intensity, as well as inter-individual differences in ex-
pression. We were also able to assemble the complete
gene structure of 100 OR intact genes, providing a fresh
general view of the encoded human OR transcripts.
Results
Differential expression
We obtained epithelial samples from the nasal cavity of 14
human subjects and three autopsies. Four of them were
identified by gene marker analysis as relatively high quality
olfactory epithelium, and were selected for RNA sequen-
cing (see Methods, Additional file 1: Table S1, Figure S1,
Additional file 2: Table S2). The olfactory epithelial tissues
portrayed a unique overall gene expression signature as
compared to 16 control tissues from the illumina Body
Map project (Fig. 1). For comparisons, we analyzed mouse
olfactory epithelial RNAseq data from different sources
(Additional file 2: Table S2), including a preparation of
isolated sensory neurons. The latter provided specific
information about the role of certain genes in this class of
neuronal cells within olfactory epithelium. Although the
mouse RNAseq came from different mouse strains, sex
and age, the correlation values between the different
strains as well as within strains was high and significant
(MOE1-MOE2 0.945, MOE1-MOE3 0.947, MOE2-MOE3
0.978, Pearson).
We next identified a set of 196 non-olfactory receptor
genes that were over- expressed (>X6) in human olfactory
epithelium relative to the illumina BodyMap control tis-
sues but not over-expressed in respiratory epithelium rela-
tive to the same controls (Fig. 2a and Additional file 3:
Table S3). Using database and literature searches we were
able to discriminate between genes with previous evidence
of an olfactory role (36 genes, class A) and genes with
little or no previous knowledge on such functional in-
volvement (158 genes, class B). Class A genes include the
expected well-known olfactory signal transduction genes
such as OMP, CNGA2, CNGA4, GNG13, ANO2, RTP1,
and RTP2. Additional genes in class A include bio-
transformation enzymes such as UGT2A2, and more
(Additional file 3: Table S4). Notably, all class A genes
are over expressed in mouse olfactory epithelium, ex-
cept NOS2.
New olfactory expression vistas
We subsequently examined the 158 class B genes and
identified 109 genes that were overexpressed in human
as well as mouse olfactory epithelium, highlighting their
putative new olfactory role (Additional file 3: Table S5).
These olfactory epithelium-enriched genes are described
below, grouped by functional subgroups (Fig. 2b).
Non-olfactory GPCRs
We identified three neuropeptide receptors, NPBWR1,
NPBWR2 and NPFFR1 (Additional file 1: Figure S2).
NPBWR1 and NPBWR2 have a role in regulating feeding
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behavior, energy homeostasis, neuroendocrine function,
and modulating inflammatory pain [26] as well as in the
regulation of emotion-related responses that affect
autonomic functions [27]. NPFFR1 has a role in GnRH
signaling of the reproductive axis [28] NPBWR1 and
NPBWR2 are receptors of the NPB and NPW neuropep-
tides. The peptide NPB, but not NPW shows sufficient
expression (1.6 FPKM) and overexpression (X2.77) in
human olfactory epithelium, to warrant notice.
Neuropeptides
This subgroup includes four neuropeptides: UCN3 and
PTH2 (class B genes), and two more well-known (class
A genes, AVP, TAC4) (Additional file 1: Figure S3). Two
of these neuropeptides, AVP and UCN3, were respect-
ively linked to the processing of social stimuli in sensory
regions of the brain [29] and to social discrimination
abilities via corticotropin-releasing hormone receptor type
2, being localized in nuclei functionally connected to the
accessory olfactory system [30]. We note that PTH2 is
highly overexpressed in isolated olfactory sensory neurons
(Additional file 3: Table S3 and Table S5), suggesting a yet
undefined role in these cells.
Ion channels
Three voltage gated potassium channels (KCNK10,
KCNH3 and KCNH4) and a chloride channel (CLIC6)
appear among class B genes (Additional file 1: Figure S4).
KCNH channels are voltage-gated potassium channels
with roles in cardiac repolarization, cellular proliferation
and tumor growth [31]. All three genes show strong
overexpression in isolated olfactory sensory neurons
(Additional file 3: Table S3 and Table S5). Future scru-
tiny could uncover a possible role in olfactory epithelial
differentiation or neurogenesis, as suggested [32]. CLIC6
(X16.5 overexpressed) is a member of the chloride intra-
cellular channel family, which functions as monomeric
soluble proteins and as integral membrane chloride ion
channels. In the soluble form they adopt a glutathione S-
transferase (GST) fold, with an enzymatic activity [33]. In
line with this, our data are consistent with function in
olfactory epithelial cells other than the sensory neurons
(Additional file 3: Table S3 and Table S5).
Solute carriers
Four proteins of this group are identified: SVOPL, member
of the SCL22 family, SLC25A35, SLC38A8 and SLC7A3
(Additional file 1: Figure S5). SVOPL is a putative synaptic
vesicle glycoprotein and its affiliation with the SLC22 fam-
ily suggests a role as organic ion transporters. Enhanced
expression of SVOPL in the olfactory bulb and cerebral
cortex has been reported [34], consistent with an olfactory
role. Yet, based on the analysis of isolated olfactory sen-
sory neurons (Additional file 3: Table S3 and Table S5),
these genes may have a role in non-sensory cells of the
olfactory epithelium. SLC38A8 functions as a neuronal
transporter with a broad amino acid transport profile and
tissue
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Fig. 1 Expression correlation of olfactory and other tissues. Pearson correlation of human olfactory epithelium and a selected set of control
tissues. Correlation was calculated for each tissue pair based on vectors with the logarithmic FPKM value of 16,288 genes. Correlation values are
on average 0.91 ± 0.0 among the olfactory epithelium tissues and 0.74 ± 0.1 between the olfactory epithelium tissues to the controls. Tissue
abbreviations: OE, human olfactory epithelium; rsp, respiratory; brn, brain; lvr, liver; kdn, kidney; lng, lung
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was suggested to have a key role in the glutamine/glutam-
ate (GABA) brain cycle [35].
Transcription factors
Thirteen transcription factors, with little or no known ol-
factory involvement are overexpressed (Additional file 1:
Figure S6). Of these we note the gene ASCL3, member of
the achaete-scute complex (ASC) family which has a role
in cell fate determination and differentiation of numerous
tissues, including neuronal tissues [36]. In drosophila
achaete-scute gene complex (AS-C) is a key component in
developing of the macrochaetes sensory organs [37]. The
paralog ASCL1 is required for early development of olfac-
tory neuron [38]. Three additional transcription factors
are UNCX, suggested to participate in the regulation of
neural progenitor cells proliferation and neuronal sur-
vival in the olfactory epithelium [39], and SP7 which
plays a role in the olfactory glomerular layer [5] and
NHLH1, a neurogenesis transcription factor whose ex-
pression in mouse olfactory epithelium and vomerona-
sal organ during development has been reported [40].
The expression data provide further support for such
roles. A specific mature olfactory sensory neuronal
function is suggested only for one of the above, UNCX
(Additional file 3: Table S3 and Table S5).
Other genes
Other genes for which we suggest a novel olfactory role
include: 1) matrilin 4 (MATN4), a member of the von
Willebrand factor A domain-containing protein family,
involved in the formation of filamentous networks in
extracellular matrix. In zebrafish MATN4 expression was
significantly increased following exposure of olfactory epi-
thelium to the odorant phenylethyl alcohol in a potential
context of memory formation [41]; 2) Leucine Rich Repeat
and Ig Domain Containing 2 (LINGO2), reported to be
expressed during mouse embryogenesis in a population of
cells lying adjacent to the epithelial lining of the olfactory
pit [42], and to be involved in the development of the
olfactory pathway of mouse and zebrafish embryos [42].
3) SPEF1, a microtubule-associated protein, that plays a
role in the structural integrity of auditory sensory epi-
thelium [43]; 4) VMO1 a protein of the outer layer of






















































































































































Fig. 2 Genes with overexpression in human olfactory epithelium. a Expression profile of all 195 overexpressed genes in different human tissues
(four olfactory epithelial and 17 controls). Right-hand side two columns show functional evidences in gray scale for every gene, based on GOSdb
scores (right) calculated without the DS6-DS9 sources [10] and on PubMed searches (left). b Expression profile for a subset of the genes in (a),
which are specifically mentioned in the Results section. White color - no mouse ortholog. Tissue abbreviations as in Fig 1, with the addition of :
MOE; mouse olfactory epithelium., adp; adipose, adr; adrenal, brst; breast, cln; colon, hrt; heart, lmph; lymph, ovr; ovary, prst; prostate, skl; skeletal
muscle, tst; testis, thyr; thyroid, bld; blood
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function in the antimicrobial barrier in avian eggs [44]
and was suggested to function in tear integrity [45, 46];
5) EFR3B, a palmitoylated plasma membrane protein,
which is responsible for maintaining an active pool of
the PI4KA enzyme at the plasma membrane. EFR3B
was recently shown to function also as a direct regulator
of GPCRs [47]. The high overexpression of three of the
above genes, LINGO2, SPEF1 and EFR3B in isolated sen-
sory neurons is noteworthy (Additional file 3: Table S3
and Table S5).
Other than that we identified several RNA genes, linc
RNA genes and antisense genes which might have a role
in the regulation of the olfactory system, three transmem-
brane protein, two Squalene Transfer Proteins (SEC14L2
and SEC14L3) and 24 other secreted proteins. Among the
secreted proteins especially high over expression is ob-
served for SCGB1C1.
Odorant binding proteins (OBPs)
Our data indicate a complex situation with respect to ol-
factory epithelial overexpressed genes that might harbor
odorant binding protein (OBP) function. In mouse 4 para-
logs genes, Obp1a, Obp1b, Obp2a and Obp2b are highly
overexpressed (Additional file 4: Table S6). These are “clas-
sical” OBPs, as indicated by their symbols, and indeed all
four are highly expressed in the mouse sensory organ.
However, in human only two of the four appear to have
orthologs bearing identical symbols (OBP2A, OBP2B,
Additional file 1: Figure S6). Surprisingly, these two genes
do not show any enhanced expression in the human sen-
sory tissue (under-expression of 0.1X and 0.32X res-
pectively and a very low absolute values of 0.12 and 0.08
FPKM respectively). In fact OBP2A, OBP2B are overex-
pressed in testis and ovary (Additional file 1: Figure S8).
This may indicate a case of functional misidentification.
The finding that human OBPs are likely to have no
olfactory role is further corroborated by the recent
OBP2B crystal structure, showing a structural features
different from those of other mammalian OBPs, includ-
ing a potentially reactive cysteine side chain within the
binding pocket, which is most similar to human tear
lipocalin [48].
Alternative human functional OBPs may be gleaned in
the broad scope orthology dendrogram of Fig. 3, show-
ing sequence relationships as well as overexpression
traits. A second gene sub-family - lipocalins with explicit
symbol prefix LCN - appears to be relevant to human
olfaction. In human there are 9 LCN genes while in
mouse there are 10 such genes. In human, only two en-
hanced sensory organ expression: LCN1 and LCN15, the
latter showing especially high overexpression. In con-












Fig. 3 Phylogenetic analysis of the lipocalin family. The evolutionary branches of OBP1 and OBP2 are marked by curly brackets. Black circles
indicate the fold change of a gene in olfactory epithelium relative to controls. The tree was constructed with MEGA6 [88] using the NJ
method [87]. Red- mouse; blue - human
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mouse sensory prominence: Lcn3, Lcn4, Lcn10, Lcn11,
with the latter being the strongest.
In addition, several BPI fold containing proteins which
were previously suggested to function as odorant bind-
ing proteins [49] are extremely overexpressed (X10,000
or more) in human olfactory epithelium. Such striking
result lends credence to a possible olfactory role, pos-
sibly in odorant carrying or removal. The null expression
in the sensory neurons (Additional file 3: Table S5) is
consistent with expression in non-neuronal secretory
cells of the olfactory epithelium or sub-epithelium.
Biotransformation enzymes
Biotransformation enzymes are involved in xenobiotic
modification and clearance [50, 51]. Some of these enzymes
have previously been reported to be expressed in the olfac-
tory epithelium and suggested to play a role in odorant
modification [52–54]. These include two cytochrome P450s
(CYP2G1, CYP2A13) and one UDP glucuronosyl transfer-
ase (UGT2A2), which are indeed overexpressed in olfactory
epithelium (Additional file 1: Figure S9, Additional file 3:
Table S5). The mouse ortholog of CYP2G1, Cyp2g1, is a
known olfactory-enriched protein [53, 55, 56] suggested to
be involved in clearance of odorous compounds [52]. An-
other seven biotransformation enzymes show high (>X10)
olfactory over expression (Additional file 1: Figure S9).
Among these, for the aldehyde dehydrogenase ALDH3A1
and the glutathione peroxidase GPX6 there are previous in-
dications for olfactory involvement [50, 57]. Four others, a
glycine acyl transferase (GLYATL3), a galactose sulfotrans-
ferase (GAL3ST2), a gamma glutamyltransferase (GGT7)
and a carbohydrate sulfotransferase (CHST8) have no re-
ported olfactory role, and their specific olfactory epithelial
expression is worthy of future scrutiny. Of note is that the
only one among the abovementioned genes that has a
strong enrichment in isolated sensory neurons is CHST8
(Additional file 3: Table S3 and Table S5).
Another biotransformation enzyme overexpressed in
human olfactory epithelium is the dopamine beta-
hydroxylase-like monooxygenase MOXD2. This en-
zyme harbors frequent loss-of-function mutations in
some apes, toothed whales and baleen whales [58]. In
human the gene inactivated due to a 2 exons deletion
[59] that is fixated in the population, as indicated by
1000 genomes and DGV scrutiny. This pseudogeniza-
tion is possibly connected to the impaired olfactory
faculties in apes and monodontidae [58] as well as in
human [60].
Olfactory receptors
We examined the expression profile of all mappable OR
genes in human olfactory epithelium (Fig. 4, Additional
file 5: Table S7). Using a cutoff of with FPKM> =0.01 [61]
we observed that 88.6 % of the intact OR genes were
expressed, while a much lower percentage (61.2 %) of the
OR pseudogenes were expressed in at least one of the tis-
sue samples. Further, intact OR genes had a significantly
higher average expression level (0.35 ± 1.08 FPKM)
as compared to OR pseudogenes (0.09 ± 0.33 FPKM,
P = 3.7X10−26, Kolmogorov-Smirnoff test, Fig. 4). Moreover,
we found a significant correlation between the predicted
probability of the OR to encode a functional protein,
computed by the CORP score [62] and its expression level
(P = 3.62e-7, Kolmogorov-Smirnoff test, Additional file 1:
Figure S10). Interestingly, in control non-olfactory tissues
the relationship is inverted, whereby OR pseudogenes have
a higher average expression than intact genes (Fig. 4). We
note that among non-olfactory tissues, the highest expres-
sion of both OR genes and pseudogenes is in testis, con-
firming a previous report [61].
We asked about trends in expression levels across the
OR repertoire. Our data clearly indicate that expression
levels of different OR loci are highly heterogeneous.
While for intact human OR genes the median is about
0.1 FPKM, the top OR is expressed at levels 100 fold
higher, and the overall span is around three orders of
magnitude (Fig. 5a). Human OR pseudogenes show a
similar trend, suggesting that protein functionality may
not be underlying correlate. It appears that variations in
the effectiveness of transcription regulation may be at
work. In mouse, while the overall expression is ~5-10 fold
higher across the board (probably due to tissue purity dif-
ferences), the inter-OR heterogeneity is less pronounced.
Interestingly, the discrepancy in expression levels between
intact and pseudogenized loci is much higher in mouse,
possibly because of the recently of pseudogenization in a
large majority human OR genes [60]. Of note is that both
species show a skew in the inter-OR expression variation,
and that this is much more pronounced in human. While
in mouse ~18 % of the ORs contribute 50 % of to the
cumulative OR expression, in human the value is ~5 %
(Fig. 5b). This may be rephrased as indicating that in the
sensory organ, the effective repertoire, in particularly in
human, is only a small fraction of the nominal repertoire.
Interestingly, the position of a given OR on the expres-
sion intensity scale portrays no ortholog-pair correl-
ation (Additional file 1: Figure S11). It might be argued
that the above observations could be misleading due to
inaccurate calling of genes and pseudogenes in human.
This is because of the fact that individual human ge-
nomes contain a high number of deleterious variations
that turn intact genes into pseudogenes in some indi-
viduals (segregating pseudogenes) [10]. We therefore
redrew Figs. 4, 5 without all 282 OR loci reported to
harbor segregating pseudogenes. The assignment of loci
to segregating pseudogene status was done base on our
previous data [10] that integrated 13 different resources,
including the 1000 genomes project as well as exome
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sequences of over 1000 individuals, including deleterious
SNPs, indels and CNVs. This process thus captured all
segregating pseudogenes with an allele frequency >0.001
in the human population. The probability that an indi-
vidual that underwent transcriptome analysis has rare
private deleterious OR mutations is further diminished
based on our statistics [10] that a typical individual
genome has on average only 46 affected OR loci out of
the population’s 282. The results shown in Additional file 1:
Figure S12 suggest a very small effect as compared to Fig. 4.
Likewise, while the results relevant to Fig. 5a seen in
Additional file 1: Figure S13A show somewhat different
trends due to the different gene count, the normalized
curves relevant to Fig. 5b (Additional file 1: Figure S13B)
are nearly indistinguishable with and without omission of
segregating pseudogenes.
Interestingly, within the mouse OR genes we find that
class II ORs have significantly higher expression level that
class I ORs (P = 7.2*1e-15, Chi Square), consistent with the
recent findings of [63]. Class II ORs have a higher expres-
sion also within the human OR expression data, although
the difference was not significant (0.06, Chi Square), per-
haps due to the low count of human class I receptors.
Inter-individual patterns of OR expression
The foregoing analyses were performed on values aver-
aged across the four human samples employed. We asked
whether there was inter-individual variations in the ex-
pression of OR genes. Such across-sample variations are
indeed visible in Fig. 4. For further validation, we com-
puted the six pairwise correlation values for the four hu-
man olfactory epithelial samples and indeed observed
lower correlation values for OR genes as compared to the
complete gene set (Fig. 6a, Additional file 1: Figure S14).
However such results could stem from noise related to
the fact that ORs typically have low expression values. To
address this, we analyzed 10,000 random subsets of a simi-
lar size to that of the OR set which obey the same FPKM
distribution as the OR genes. For OE12, OE15 and OE17
this simulation demonstrated that the correlation values
for the OR gene set lie completely outside the distribution
for the 10,000 control gene sets (Fig. 6b). Thus for these
tissues the expression level of the ORs is significantly
more variable than that of other genes. When OE7 was
compared to each of the other three tissues, no significant
inter-individual differences were observed (Fig. 6b legend).




































































Fig. 4 Expression profiles of OR genes. a the average expression of OR genes and pseudogenes per enumerated tissue. b, c respective expression
profile for the same tissues for intact and pseudogenized genes. Tissue abbreviations as in Fig 2
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A potential weakness of the conclusions regarding
inter-individual differences in OR expression patterns is
that some such difference could arise due to differences
in the counts of intact OR alleles in different individuals
[10]. To address this, we redrew Fig. 6 and Additional
file 1: Figure S14 in a version that excludes all gene loci
previously reported [10] to harbor segregating pseudo-
genes (Additional file 1: Figures S15-16). The results
were nearly identical to the original.
Genomic structure of OR transcripts
We used uniquely-mapped RNAseq reads from all human
olfactory epithelial samples to assemble transcripts for in-
tact OR genes. After a curation process we obtained 311
transcripts representing 210 intact OR genes. Of these,
120 transcripts with expression level <1.0 FPKM were
excluded to avoid inaccuracies in transcript assembly, and
the remaining 163 transcripts (encoded in 100 genes) were
further analyzed (Fig. 7 and Additional file 1: Figure S17,
Additional file 6: Table S8). The OR transcripts obtained
were 4097 ± 2053 bp long and spanned genomic lengths
of 8103 ± 3464 bp. The coding exon contains an open
reading frame of 940 ± 16 bp and 3’ UTR of 2777 ±
2047 bp (Fig. 8). The 5’ UTR is 389 bp long, and contains
0–3 non-coding exons (Fig. 7). The number of splice vari-
ants per gene varies from 1 to 5 (Fig. 7). Of note are 10
OR genes with a seemingly non-functional transcript that
skips the initiating methionine (Fig. 7), suggesting a yet
unreported OR pseudogenization mechanism. Eight of
these aberrant transcripts show the co-existence of both
functional and non-functional transcripts, indicating the












































Fig. 5 Rank plots for the expression values of human and mouse ORs. a Ranked expression values. Red and pink respectively represent intact and
pseudogenized mouse OR genes; Blue and light blue respectively represent intact and pseudogenized human OR genes. b Normalized
cumulative expression values, colors as in (a)
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Our data provide repertoire-wide information on the
gene structure of intact human OR genes. For comparison,
we screened the AceView gene model repository [64], cal-
culated from public expressed sequences and found 279
AceView transcripts that harbor also untranslated regions.
However, only 36 of them (12.9 %) are spliced, with a sub-
stantial shorter the 3’UTR (159 ± 352 bp), probably due to
the insufficient coverage in non-olfactory cDNA libraries.
In the case of one gene, OR51E2, known to be highly
expressed in prostate [65], we identified potential disparate
tissue-specific promoters. The proximal promoter appears
to be active in olfactory epithelium, while the distal pro-
moter – in prostate (Additional file 1: Figure S18). The
latter is inferred from AceView data, as well as well as
from the prostate Illumina Body map data.
The OR promoter region
We used the Genomatix RegionMiner tool to search for
significant over representation of transcription factors
binding sites (TFBS) immediately upstream from the in-
ferred transcription start site. This was done jointly ana-
lyzing all 160 OR transcripts, with a comparison to the
a
B












Fig. 6 Inter-individual patterns of OR expression. a Inter-individual correlation of the ORs expression level (red) versus the whole genome (grey) for
samples OE12 and OE15. Data are presented on a log10 scale of the FPKM values. The Pearson correlation values are 0.35 for the OR genes and 0.9 for
the whole genome. The complete data set is shown in Additional file 1: Figure S12. b Pearson correlation values for OE pairs shown by arrows:
OE12,OE15 - red, OE12, OE17 – black, OE15, OE17 - blue. Also shown are distributions of Pearson correlation values obtained from 10,000 random sets
for the respective pairs with same color code. The respective P values for the above pairs are <0.0001, 0.0004 and <0.0001. For the other three pairwise
comparisons involving OE7 the P values were 0.0801 (OE7,OE12), <0.0001 (OE7, OE15), 0.46 (OE7-OE17), i.e. not significant (see text)
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Genomatix genome-wide promoter region collection.
The top 10 TFBS of all belonged to homeodomains class,
including Genomatix families V$LHXF and V$HBOX.
These respectively include the transcription factors LHX2
and EMX2, previously shown to be required to the ex-
pression of OR genes [66, 67]. The results are also in
agreement with a similar analysis of mouse OR pro-
moters [21, 68]. Repeating the analysis with a whole
genome reference, or with promoters with matched low
GC content (<60) to that of presumed OR promoters,
identified an enrichment of the V$NOLF family of the
Early B-Cell Factor (EBF) proteins, involved in the expres-
sion of ORs [39]. These V$NOLF TFBS are clustered in a
distance of 100–300 bp from the transcription start site
(Fig. 9), in broad agreement with the mouse data [21, 68].
The appearance of a distinct propensity peak for V$NOLF




The human olfactory epithelium is relatively difficult to
obtain in a high quality, due to anatomical inaccessibility
and heterogeneous boundaries. Specifically, there is
variable contamination with non-sensory respiratory epi-
thelium [6]. We succeeded in doing the analysis by
examining biopsy and autopsy samples form 17 different
human individuals, and selecting the ones most-enriched
for known olfactory markers. Further, the gene-specific
signals were filtered with respect to respiratory epithelial
over-expression. This enables us to report a dependable
-15 -10 -5 0 5 10
Distance from CDS (kb)
Fig. 7 Genomic maps of OR transcripts. Transcripts are presented on a genomic scale, phased by the OR open reading frame (vertical thin lines).
Thick blue/red lines are exons and thin gray lines are introns. Narrowly spaced transcripts are for the same OR gene. Transcripts with a disrupted
open reading frame are in red. These are: OR52K1, OR2V1, OR6C75, OR4M1, OR51L1, OR2A1, OR10H4, OR2K2, OR2J3 and OR6F1
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and comprehensive transcriptomic view of this human
sensory tissue.
New vista of olfactory auxiliary genes
We identified a large number of olfactory auxiliary
genes, those playing a role in transduction, development
and maintenance [10]) (Additional file 3: Table S3 and
Additional file 7: Table S9). Our working hypothesis was
that many of these would be highly expressed in human
olfactory epithelium. It is clear that such correlation may
not be perfect, i.e. genes that play a role in development
and maintenance are not necessarily olfactory specific
-4000 -2000 0 2000 4000 6000 8000 10000
CDS CDE
OR transcript
Fig. 8 The OR transcripts. The transcripts are justified to the initiating methionine. The 5’ UTR region is in red, coding region in blue and 3’ UTR in light blue








distance from TSS (bp)
tnuoc
Fig. 9 Upstream binding site profile for the EBF family of transcription factors. Shown are summed counts of predicted binding sites in a 4 kb
interval upstream to the transcription start site (TSS). This applies only OR genes for which a transcript defines one or more TSS
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and expressed at higher levels. Still, there is a relatively
broad consensus that tissue-specific expression has func-
tional implications [21, 69, 70].
It is also noteworthy that tissues are often heteroge-
neous, and a prominent example is olfactory mucosa,
which includes sensory and supporting cells, basal pro-
genitor cells and subepithelial Boman’s gland cells. Fur-
ther, tissue contamination may occur, e.g. with respiratory
epithelium. However, as we set our overexpression cutoff
of X6, a 10 % contaminating tissue would have to show
X60 overexpression of a gene, and such high spurious
expression signal would be easily excluded by our use of
respiratory epithelium control. To summarize, equating
olfactory epithelial over-expression with chemosensory
function should be taken with caution, but is a relatively
high probability premise.
In a first group are genes that are already well-known
to play a key role in olfactory function. Some such genes
are found to be significantly overexpressed in the sen-
sory tissue (e.g. OMP, GNG13 and ANO2), while others
were not, due to a broader appearance in non-olfactory
tissues (e.g. GNAL and ADCY3).
In the second group are genes that have very few or
no previous publications on olfactory involvement. Some
of these genes are also highly expressed in mouse olfac-
tory epithelium, as also reported [32]. Such inter-species
concordance increases the probability of olfactory in-
volvement for those genes.
Apparent species-specific genes
Among the 194 olfactory over-expressed genes in hu-
man, we identified 58 that do not show over expression
in mouse, or do not have a mouse ortholog. Such dis-
cordance suggests inter-species functional differences
between mammals that need to be further elucidated. In
an example, we showed the different patterns of expres-
sion of the broadly-defined lipocalin family members,
where human and mouse show differential expression in
disparate members of the family. Likewise, while in
mouse several TAAR genes are overexpressed, in human
only one paralog (TAAR5) shows such differential ex-
pression. These results may suggest that in evolution,
different protein family members assume a chemosen-
sory role. We note that some of these inter-species dis-
crepancies could rest in the fact that the mouse data
were obtained from samples pooled from four animals,
which likely included a better representation of the ol-
factory epithelium, while the human anatomical sam-
pling was more heterogeneous.
Expression of olfactory receptors
The RNAseq data accumulated in this study provide an
informative view on the expression of OR genes in
olfactory epithelium and other tissues. In the olfactory
tissue we observed the expression of nearly 90 % of the
intact OR repertoire, but only ~60 % of all OR pseudo-
genes. Further, the expression distribution curve of pseu-
dogenes is shifted to ~ X4 lower intensity relative to
intact genes (Fig. 4a). This may be due to the accumu-
lation of promoter mutations or to nonsense mediated
decay. In non-olfactory (ectopic) tissues the typical ex-
pression of intact OR goes down about X7, while at
least in some such tissues the pseudogene expression
is not much altered. This may reflect in part the func-
tional feedback mechanism that selects against pseudo-
gene expression [71].
An intriguing finding is the three orders of magnitude
difference in expression intensity of different members
of the OR repertoire, both in human and in mouse. This
phenomenon has been previously observed in mouse by
other methodologies [20, 72], and may be accounted for
in part by variations in transcription regulatory efficiency
along OR gene clusters. Here we add a functionally rele-
vant dimension to this observant, namely that the de-
cline of OR expression in the rank curve is much faster
in human as compared to mouse, hence the overall (in-
tegral) repertoire expression is considerable weaker in
human (Fig. 5b).
Finally, we observe significant inter-individual differ-
ences in the across-repertoire pattern of OR expression
as compared to whole genome measures, consistent with
previous reports [73, 74]. It important to ask whether
this phenomenon is a true inter-individual difference,
with a potential genetic basis, or due to sampling arte-
fact. The expression of different ORs is known to vary
strongly among different anatomical zones of rodent ol-
factory epithelium. Thus, one possible explanation could
be that in different individuals tissue samples were from
different functional zones, though zonal OR expression
has not yet reported in human. If the mechanism is gen-
etic after all, one potential explanation is inter-individual
difference in OR regulatory sequences. Alternatively,
genetic variations elsewhere could be responsible. Clari-
fying these issues requires to perform extensive expres-
sion quatitativew trait loci (eQTL) experiments, whereby
genome sequencing a transcriptome analyses is con-
comitantly performed on the same individuals. As this
far transcends the scope of the present study, it should be
clearly stated that the inter-individual expression variation
trends reported here should be taken with significant cau-
tion. Likewise, if one wishes to extend such results to
mouse, this would necessitate comparing several different
mouse trains, again beyond the present scope.
The OR transcript
Despite the low expression of individual OR genes, we
succeeded in defining the exon-intron structure of 160
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transcripts in 100 OR genes, those that show higher ex-
pression. We are aware of the possibility that because of
the relatively low coverage, some of the features de-
scribed herein represent transcript-mapping artifacts.
The 160 transcripts elucidated may well be a representa-
tive sample, as a correlation between gene structure de-
viations and expression strength is not very likely, and as
no OR family bias has been observed along the expres-
sion rank curve (not shown).
The OR transcripts have certain common features.
These include 1–4 short 5’ non-coding exons with con-
siderable alternative splicing: 43 of the 100 genes having
2–4 splice variants; long last 3’ exon which contains the
entire OR coding region, i.e. no introns are seen within
the coding region. At the same time, considerable struc-
tural variability is seen in 5’ exon count, as well as intron
length and 3’UTR length (Fig. 7). One interesting case is
that of OR51E2, which in olfactory epithelium contains the
coding exon spliced to one 5’ non-coding exon. In pros-
tate, the same coding exon is spliced to a remote 5’ non
coding exon of a neighboring OR pseudogene OR51C1P.
This chimeric transcript is known to be highly expressed
in prostate, and appears to bear a functional role in this
tissue [75].
OR genes have undergone a massive recent evolution-
ary process of pseudogenization [60]. OR pseudogenes
do not arise by retroposition, but rather by gradual accu-
mulation of point mutations and indels that render the
encoded protein aberrant. We report here an additional
pseudogenization process that affects 15 transcripts in
10 OR genes with an intact open reading frame. These
events stem from inappropriate slicing, eliminating
part or the entire coding region. We note that only in
three of the cases no intact OR-encoding splice variant
remains.
The analysis performed allowed us to accurately define
for the first time the transcription start site (TSS) of 100
human OR genes. We subsequently analyzed the tran-
scription regulatory elements immediately upstream to
the TSS. The results indicated an enrichment of tran-
scription factor binding site signature belonging to the
large homeobox family in that region. In addition, we
found a consensus localization of a specific transcription
factor binding site subfamily (Olf/EBF). In mouse, these
binding sites are known to be present in promoter re-
gions of the OR repertoire, and to play a key role in OR
transcription [21, 68].
Conclusions
We report the first RNAseq study of human olfactory
epithelium, aimed at obtaining a whole transcriptome
overview of the sensory tissue. Our work reveals nearly
200 olfactory-enriched non-receptor transcripts, 80 % of
which have not yet been implicated in chemosensory
function, thus providing a platform for future discovery.
Our study further allowed us to quantitate the expres-
sion levels of most (90 %) of the ~400 intact human ol-
factory receptor (OR) genes. The expression levels of
different paralogous members of the OR repertoire span
a 1000-fold range, suggesting a strong imbalance among
different odorant specificities. Further, we obtained con-
vincing hints that different human beings show different
cross-repertoire expression patterns. Having successfully
assembled transcripts for 100 OR genes, we observed
prevalent genome-encoded mutations that render some
transcripts inactive despite the fact that the protein cod-
ing region is intact, an unreported mechanism for OR
pseudogenization.
In sum, our transcriptome study offers important ob-
servations on genes that underlie olfactory function and
provides a basis for significant future work.
Methods
Samples collection
Human olfactory epithelium samples
We obtained 14 biopsy tissues and three autopsy tissues
of human olfactory epithelium biopsies dissected from
the superior ethmoturbinal, the cribriform plate and
the superior septum [73, 76] during elective surgeries
of the samples donors. We used qPCR (see below) to
characterize the olfactory content of 12 of the biopsies
samples (Additional file 1: Figure S11A), and measure
the expression level of olfactory markers (CNGA2,
GNAL, OMP) versus respiratory markers (KRT13 [77]
and TMPRSS11D [78]). Three samples (OE12, OE15 and
OE17) were selected for RNAseq and analysis. A third
biopsy sample (OE7) was selected for analysis based on
the expression of the olfactory markers in the RNAseq re-
sults (Additional file 1: Figure S1B and Table S1). The
other samples were excluded from the analysis, as they
failed to show expression of olfactory markers.
The study was approved by the Ottawa Health Science
Network Research Ethics Board and the Ethics Board of
University Rehabilitation Institute (Ljubljana, Slovenia).
All participants provided informed consent.
Mouse samples
C57BL/6 mouse olfactory epithelium and mouse olfac-
tory bulb RNA (Additional file 1: Table S1 samples
MOE1 and MOB) were collected in pool from four adult
female Trpm5-GFP mice crossed with C57BL/6 for over
10 generations. These experiments were performed
according to protocols approved by the University of
Colorado Anschutz Medical Campus Institutional Animal
Care and Use Committee. BALB/c olfactory epithelium
RNAseq data were kindly provided by Wen-Hsiung Li,
Academia Sinica, Taiwan [79]. Of note, the MOB sample
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was used only for presentation in Additional file 1: Figures
S2-S6, S8, and S9.
Mouse olfactory sensory neurons
Single dissociated cells of olfactory sensory neurons were
randomly selected under a light microscope and seeded
into a tube containing cell-lysis buffer by mouth pi-
petting. After reverse transcription and global amplifica-
tion of cDNA, diagnostic PCR for four mature olfactory
sensory neuron marker genes (olfactory marker protein
(Omp); guanine nucleotide binding protein; alpha stimu-
lating, olfactory type (Gnal); cyclic nucleotide gated chan-
nel alpha 2 (Cnga2) and adenylate cyclase 3 (Adcy3)) was
carried out using the diluted amplified cDNA. Samples
with the presence of all of four markers were selected for
library preparation and sequencing by following the Illu-
mina protocol. After aligning the read data to the mouse
genome (mm9) an expression profile was generated using
only the uniquely mapped reads and those that are
mapped to exons. The number of reads per gene was fur-
ther divided by the total number of the sample mapped
reads (reads per million, RPM). The data presented in this
manuscript is the average of nine olfactory sensory neu-
rons collected from female Mus musculus domesticus
(C57BL/6, B6) and an hybrid mice from cross of male
Mus spretus (Spretus) and female B6.
Control samples
The Illumina human body map 2.0 project data contain-
ing RNAseq of sixteen normal human tissues were used




cDNA was synthesized with the SuperScript® First-strand
Synthesis System for RT-PCR (Invitrogen, Carlsband, CA,
USA) according to the manufacturer’s instructions.
Quantitative real-time polymerase Chain Reaction (qPCR)
qPCR reactions were performed using TaqMan® Gene Ex-
pression Assays (Applied Biosystems, Foster City, CA,
USA). A total of 2ul of cDNA was added with 2.5ul of
water and 0.5ul TaqMan® Gene Expression Assay to 5 ul of
TaqMan® universal PCR Master Mix (Applied Biosystems)
and the resulting 10 ul reaction mixtures were loaded onto
a 96-well PCR plate. We used eight different TaqMan®
Gene Expression Assays including three housekeeping
genes with the following assays IDs: Hs01087269_s1
(OMP), Hs00181836_m1 (GNAL), Hs00864448_s1 (RT
P1), Hs01377537_m1 (CNGA2), Hs00975370_m1 (TM
PRSS11D), and ACTB (Hs99999903_m1) and GAPDH
(Hs99999905_m1) as housekeeping genes.
Next generation sequencing-OE, MOE1 and the olfac-
tory respiratory sample were sequenced at the biological
services of the Weizmann institute using the Illumina
Genome Analyzer platform (Illumina GA IIx) and the
standard Illumina protocol at the experiment time.
Samples OE12-OE17 were sequenced at Macrogene
(Seoul, Korea). RNA samples were evaluated by ultra-
violet spectroscopy for purity and concentration (Nano-
Drop, Wilmington, DE) and were assessed further for
RNA integrity on the Agilent Bioanalyzer (Santa Clara,
CA). Libraries were prepared using the Illumina mRNA-
seq Sample Preparation Kit (San Diego, CA) and validated
with an Agilent Bioanalyzer (Santa Clara, CA).
Data analysis
Gene expression quantification
Reads of human olfactory epithelium were aligned to
the hg19 reference genome using Tophat 2.0.4 [80].
Quantification of expression level was performed with
Cufflinks v2.1.1. [81] using Ensembl transcripts and
HORDE build#43 annotation [10] of OR genes and
pseudogenes. To enable downstream calculations, 0
FPKM values were set to 0.003. Mouse data were an-
alyzed with the same procedures using Mm10 as a
reference genome. The GeneAlaCart tool of the Gen-
eCards database [82] was used to find the mouse
ortholog of each human gene.
Differential expression
To test the statistical significance of over expression in
the olfactory epithelium versus the controls we used
HTSeq [83]] to count the number of uniquely mapped
reads per gene, following by the R package DESeq [84],
using the illumina Body Map samples as control tissues.
Genes with a fold change ≥ 6 and p <0.001 were consid-
ered as statistical significant. To overcome contamin-
ation from respiratory epithelium genes with expression
in the respiratory epithelium that exceeded 0.1 of the ex-
pression in the olfactory epithelium were removed. We
also included genes with a significant over expression in
mouse olfactory epithelium provided that their over ex-
pression in human olfactory epithelium was above 6.
The same analysis was applied to the mouse olfactory
epithelium data. In the absence of mouse controls at the
time that the analysis was performed, we used the illu-
mina Body Map samples as controls [10]. Later on, with
the progress of the mouse ENCODE project, we verified
the over expression of the significant genes against a set
of 11 mouse tissues (bone marrow, cerebellum, cortex,
heart, intestine, kidney, liver, lung, spleen, testes, thy-
mus) from the Mouse ENCODE project (http://chromo
some.sdsc.edu/mouse/download.html).
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Prior information on overexpressed genes
To associate between a given gene and olfaction we per-
formed an automatic search in PubMed with the gene
symbols of the olfactory enriched genes and a set of ol-
factory related keywords (olfactory;olfaction;odorant;o-
dor;chemosensory;smell). Followed by a manual curation
of some genes, the number of PMID hits was used to
classify genes into class A or B.
Analysis of the lipocalin protein family
Most of lipocalin family members have no orthologs.
Therefore over expression of mouse lipocalin genes were
calculated using Mouse ENCODE data (http://chromo
some.sdsc.edu/mouse/download.html) while over expres-
sion of human lipocalins was calculated relative to the
human Illumina Body Map. Only tissues that are shared
between the two control data sets were used in the cal-
culation (adipose, brain, heart, kidney, liver, lung and
testis), although the fold change of the over expressed
genes did not altered when including the complete
data set.
Assembly of OR isoforms
Uniquely mapped reads of all four studied olfactory
epithelium samples were joined to assemble the OR
transcripts. We used all reads from the OR territories
defined as HORDE OR clusters [10] extended by 300 kb
to the 5’ and 3’ of each cluster as an input to cufflinks,
and applied the parameters -A 0.15 –trim-3-dropoff-frac
0.15. Cuffcompare [81] was used for gene identification.
Transcripts encoded on the opposite strand of the OR
genes and transcripts that are suspected as polymerase
run-on fragment (cuffcompare classcodes x, s and p)
were removed. We also removed isoforms with expres-
sion level <0.15 % of the major isoform of a gene. Tran-
scripts with a single exon of > 5 kb length were curated
by manual inspection.
Testing inter-individual differences of
To test the significance of OR expression we used all 264
OR genes that are expressed in all olfactory epithelium tis-
sues and compared their expression to a control set of
15,846 protein coding genes which are also expressed in
all tissues. The distribution of the ORs was calculated.
We then randomly selected 264 control genes such
that their distribution will follow that of the ORs tested
by Kolmogorov-Smirnov p > 0.05. The process was re-
peated 10,000 times. Samples OE12-17, which proved
to contain the highest olfactory epithelium content,
and show the highest similarity, were used for this test.
Data-mining of AceView gene model
AceView transcripts [64] which overlap the OR coding
regions were downloaded using the UCSC TableBrowser
tool of the [85]. We then applied cuffcompare software
against a gtf file of HORDE genes to assign the tran-
scripts to the OR genes. Transcripts that overlap the op-
posite strand (cuffcompare class code x) were removed.
Promoter analysis
The tool RegionMiner of Genomatix was used to search
for over representation of TFBS in the OR upstream re-
gions. We used an interval of −750 bp and +250 of the
TSS of each transcript. Transcripts representing the
same OR gene were included if their upstream regions
did not overlap by ≥ 500 bp. The analysis compared the
sequences to a library of RefSeq promoters.
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Additional file 2: Table S2. Whole genome expression of the studied
samples (in FPKM). FC_OE, the fold change of the human olfactory
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tissues were used as controls in the calculation. MOE_encode: the fold
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mouse olfactory epithelium. In bold- genes mentioned in the manuscript
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Symbols with * are from GeneCards (http://www.genecards.org/), with an
informal gene name. (XLSX 1879 kb)
Additional file 4: Table S6. Expression of the lipocalin family
members. Mouse was calculated relative to Mouse ENCODE data
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Additional file 5: Table S7. Expression profile of the OR repertoire.
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(XLSX 37 kb)
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